Go back to Resources
A Randomized 36-Week Crossover Trial Comparing Ranibizumab and Bevacizumab for Diabetic Macular Edema
3/5/2015
Conference Paper
Authors:
Secondary:
2015 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO)
Location: Denver, CO
URL:
http://www.arvo.org/Annual_Meeting/Past_Annual_Meetings/